Go
View All
Asparaginase
AVR
Axial contrast enhanced CT scan in a patient with a left level III enlarged heterogeneous node with ill-defined margins, infiltrating the adjacent fat and sternocleidomastoid muscle
Axial T1 post-contrast fat-saturated MR imaging demonstrates a large heterogeneous and enhancing left level II mass with ill-defined margins and infiltration into the adjacent fat and sternocleidomastoid muscle
Myeloproliferative neoplasms (MPN)
N1a is defined as metastasis in one regional lymph node
N1a is described as one or two lymph nodes metastasis each less than 5 mm
N1b is described as one lymph node metastasis 5 mm or greater
N1 disease is defined as a single or multiple regional lymph node involvement
N1 is defined as involvement of regional lymph nodes
N1 is pelvic or inguinal lymph node metastasis
N2a is defined as metastasis in 4 to 6 regional lymph nodes
N2a is described as three or more lymph node metastases each less than 5 mm
N2b is described as two or more lymph node metastases 5 mm or greater
N2b showing nodal masses in more than 7 regional lymph nodes
N2c is described as lymph node(s) with extranodal extension
N2 is defined as in-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) without lymph node metastasis
N3 is described as fixed or ulcerated regional lymph node metastasis
Nasopharyngeal carcinoma (NPC)
National diabetes data group criteria
National lipid association guidelines
National lung screening trial (NLST)
Natural history of GIST
Neuroendocrine tumors (NETs)
New oral anticoagulation agents (NOAC)
New York Heart Association (NYHA)
Displaying items 211 - 240 of 1114